Search results for "reactions"

showing 10 items of 631 documents

Negative biopsy of focal hepatic lesions: Decision tree model for patient management

2019

OBJECTIVE. The purpose of this study was to investigate patient- and procedure-related variables affecting the false-negative rate of ultrasound (US)-guided liver biopsy and to develop a standardized patient-tailored predictive model for the management of negative biopsy results. MATERIALS AND METHODS. We retrospectively included 389 patients (mean age ± SD, 62 ± 12 years old) who had undergone US-guided liver biopsy of 405 liver lesions between January 1, 2013, and June 30, 2015. We collected multiple patient- and procedure-related variables. By comparing pathology reports of biopsy and the reference standard (further histology or imaging follow-up), we were able to categorize the biopsy r…

AdultImage-Guided BiopsyMalemedicine.medical_specialtyRadiology Nuclear Medicine and ImagingFalse Negative Result030218 nuclear medicine & medical imaging03 medical and health sciencesCore biopsyFalse-negative result0302 clinical medicineBiopsymedicineHumansFalse Negative ReactionsUltrasonography InterventionalAgedRetrospective StudiesAged 80 and overFine-needle aspirationmedicine.diagnostic_testUS-guided liver biopsybusiness.industryLiver DiseasesDecision TreesUltrasoundnutritional and metabolic diseasesGeneral MedicineMiddle AgedPatient managementDiagnostic errorFine-needle aspiration030220 oncology & carcinogenesisLiver biopsyFemaleRadiologybusinessCore biopsyDecision tree model
researchProduct

Development of a Peptide-Based Sandwich Elisa for Human Tissue Prokallikrein with No Cross-Reactivity from Mature Kallikrein

2000

Human tissue prokallikrein is the enzymatically inactive zymogen of a serine proteinase involved in the liberation of vasoactive kinin peptides, and it is supposed that an impaired prokallikrein-to-kallikrein conversion is closely related to certain hypertensive and inflammatory disorders. Progress in understanding the biological role of the proenzyme has been limited by the absence of an accurate assay for the kallikrein precursor. We describe a sandwich enzyme-linked immunosorbent assay to measure human tissue prokallikrein using monospecific anti-peptide antibodies raised against propeptide derivatives. This method could detect a minimum concentration of 60 pg/ml prokallikrein and displa…

AdultImmunologyTissue kallikreinEnzyme-Linked Immunosorbent AssayPeptideCross Reactionsmedicine.disease_causeSensitivity and SpecificityCross-reactivityZymogenmedicineHumansProtein precursorPharmacologychemistry.chemical_classificationEnzyme Precursorsmedicine.diagnostic_testChemistryReproducibility of ResultsKallikreinKininMolecular biologyPeptide FragmentsBiochemistryImmunoassayKallikreinsJournal of Immunoassay
researchProduct

Complement fixation test in the study of Australia antigen

1971

1810 serum samples obtained from 315 patients with various liver diseases, 44 with miscellaneous non-hepatic diseases and 1133 healthy subjects were assayed for Australia antigen by complement fixation (CF) and immunodiffusion (ID) tests.

AdultLiver CirrhosisMaleHepatitis B virusImmunodiffusionmedicine.medical_specialtyCirrhosisAdolescentCross ReactionsBiologyHepatitisHepatitis B AntigensMedical microbiologyAntigenAntibody SpecificityVirologymedicineHumansHepatovirusChildAgedHepatitisImmune SeraLiver DiseasesComplement Fixation TestsHealthy subjectsAlanine TransaminaseGeneral MedicineHepatitis AMiddle Agedmedicine.diseaseComplement fixation testVirologyImmunodiffusionEvaluation Studies as TopicChild PreschoolAcute DiseaseChronic DiseaseImmunologyFemaleViral hepatitisArchiv f�r die gesamte Virusforschung
researchProduct

Guinea pig transglutaminase immunolinked assay does not predict coeliac disease in patients with chronic liver disease

2001

BACKGROUND—It has been suggested that serological screening for coeliac disease (CD) should be performed in patients with chronic unexplained hypertransaminasaemia.
AIMS—To evaluate the specificity for CD diagnosis of serum IgA antitissue transglutaminase (tTG) determination in consecutive patients with chronic hypertransaminasaemia using the most widely utilised ELISA based on tTG from guinea pig as the antigen.
PATIENTS AND METHODS—We studied 98 patients with chronic hypertransaminasaemia, evaluated for the first time in a hepatology clinic. Serum anti-tTG and antiendomysial (EmA) assays were performed. Patients positive for EmA and/or anti-tTG were proposed for intestinal biopsy. Finally…

AdultLiver CirrhosisMalemedicine.medical_specialtySettore MED/09 - Medicina InternaCirrhosisAdolescentHepatitis Viral HumanTissue transglutaminaseGuinea PigsAutoimmunityEnzyme-Linked Immunosorbent AssayChronic liver diseaseSensitivity and SpecificityCoeliac diseaseArticleStatistics NonparametricAntiendomysial antibodieIntestinal histologySerologyLiver diseaseIntestinal mucosaPredictive Value of TestsInternal medicinemedicineAnimalsHumansFalse Positive ReactionsTransaminasesAutoantibodiesTransglutaminasesCoeliac diseasebiologybusiness.industryAntitissue transglutaminase antibodieGastroenterologyHepatologyMiddle Agedmedicine.diseaseImmunoglobulin ACeliac DiseaseImmunologyChronic Diseasebiology.proteinLinear ModelsFemalebusinessLiver disease
researchProduct

Gastrointestinal disturbances and their management in miglustat‐treated patients

2011

Miglustat (Zavesca®) is approved for the oral treatment of adult patients with mild to moderate type 1 Gaucher disease (GD1) for whom enzyme replacement therapy is unsuitable, and for the treatment of progressive neurological manifestations in adult and paediatric patients with Niemann-Pick disease type C (NP-C). Gastrointestinal disturbances such as diarrhoea, flatulence and abdominal pain/discomfort have consistently been reported as the most frequent adverse events associated with miglustat during clinical trials and in real-world clinical practice settings. These adverse events are generally mild or moderate in severity, occurring mostly during the initial weeks of therapy. The mechanis…

AdultLoperamideAbdominal painmedicine.medical_specialty1-DeoxynojirimycinMalabsorptionDrug-Related Side Effects and Adverse ReactionsGastrointestinal DiseasesModels BiologicalGastroenterologyInternal medicineMiglustatGeneticsmedicineHumansEnzyme InhibitorsChildAdverse effectGenetics (clinical)Clinical Trials as TopicGaucher Diseasebusiness.industryEnzyme replacement therapymedicine.diseaseClinical trialEndocrinologymedicine.symptombusinessFlatulencemedicine.drugJournal of Inherited Metabolic Disease
researchProduct

Meat allergy associated with galactosyl‐α‐(1,3)‐galactose (α‐Gal)—Closing diagnostic gaps by anti‐α‐Gal IgE immune profiling

2017

Background Glycoproteins and glycolipids of some mammalian species contain the disaccharide galactosyl-α-(1,3)-galactose (α-Gal). It is known that α-Gal is immunogenic in humans and causes glycan-specific IgG and also IgE responses with clinical relevance. α-Gal is part of the IgE-reactive monoclonal therapeutic antibody cetuximab (CTX) and is associated with delayed anaphylaxis to red meat. In this study, different α-Gal-containing analytes are examined in singleplex and multiplex assays to resolve individual sensitization patterns with IgE against α-Gal. Methods Three serum groups, α-Gal-associated meat allergy (MA) patients, idiopathic anaphylaxis (IA) patients with suspected MA, and non…

AdultMale0301 basic medicineAllergyMeatmedicine.medical_treatmentImmunologyDot blotCross ReactionsImmunoglobulin EArticleYoung Adult03 medical and health sciences0302 clinical medicinemedicineHumansImmunology and AllergyMultiplexAnaphylaxisSensitizationAgedbiologybusiness.industryImmunochemistryGalactoseAllergensImmunoglobulin EMiddle Agedmedicine.diseaseRed Meat030104 developmental biologymedicine.anatomical_structure030228 respiratory systemCase-Control StudiesImmunologyMonoclonalbiology.proteinFemaleThyroglobulinbusinessFood HypersensitivityAnaphylaxisAllergy
researchProduct

How we prevent and treat differentiation syndrome in patients with acute promyelocytic leukemia

2014

Abstract Differentiation syndrome (DS), formerly known as retinoic acid syndrome, is a relatively common and potentially severe complication seen in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and/or arsenic trioxide. The full-blown syndrome consists of unexplained fever, weight gain, dyspnea with pulmonary infiltrates, pleuropericardial effusion, hypotension, and renal failure. Most measures currently used for management of DS have very little evidence-based support, and therefore, many remain controversial. Despite the lack of evidence supporting DS prophylaxis, several groups have adopted a preventive strategy with corticosteroids, especially for patie…

AdultMaleAcute promyelocytic leukemiamedicine.medical_specialtyDrug-Related Side Effects and Adverse ReactionsPremedicationImmunologyTretinoinBiochemistryArsenicalslaw.inventionchemistry.chemical_compoundArsenic TrioxideLeukemia Promyelocytic AcutelawTretinoinInternal medicinemedicineHumansArsenic trioxideIntensive care medicineDexamethasonebusiness.industryOxidesSyndromeCell BiologyHematologymedicine.diseaseIntensive care unitDiscontinuationRetinoic acid syndromeLeukemiachemistryFemalebusinessmedicine.drugBlood
researchProduct

Autoantibodies to human asialoglycoprotein receptor in autoimmune-type chronic hepatitis.

1990

Autoantibodies to the human asialoglycoprotein receptor (anti-h-ASGPR) were studied with a solid-phase ELISA in the sera of 421 patients with inflammatory liver diseases, 288 patients with various other disorders and 31 controls. Anti-h-ASGPR were found predominantly in autoimmune chronic active hepatitis (44 of 88, 50%) and were closely related to inflammatory activity. In a subpopulation of these patients with untreated, biopsy-proven active disease or relapse, 15 of 17 were positive (88%). In contrast, only 11 of 204 patients (5.3%) with viral hepatitis were anti-h-ASGPR receptors-positive (chi 2 analysis; p less than 0.001). We also compared the occurrence of anti-h-ASGPR with antibodie…

AdultMaleAdolescentEnzyme-Linked Immunosorbent AssayAsialoglycoprotein ReceptorBiologyCross Reactionsdigestive systemAutoantigensAutoimmune DiseasesHepatitisEpitopesAntigenmedicineAnimalsHumansReceptors ImmunologicReceptorAgedAutoantibodiesAutoimmune diseaseHepatitisHepatologyAutoantibodyMiddle Agedmedicine.diseaseRatsImmunologyChronic Diseasebiology.proteinAsialoglycoprotein receptorFemaleRabbitsAntibodyViral hepatitisHepatology (Baltimore, Md.)
researchProduct

Cor a 1–reactive T cells and IgE are predominantly cross-reactive to Bet v 1 in patients with birch pollen–associated food allergy to hazelnut

2013

Background IgE- and T-cell cross-reactivity contribute to the birch pollen–food syndrome. Objectives We performed a comprehensive analysis of T-cell cross-reactivity in primary cell cultures, facilitating the identification of allergen-specific T-cell subpopulations from individual patients. Methods Patients with birch pollen allergy and associated food allergy to hazelnuts, carrots, or both were analyzed for IgE cross-reactivity, T-cell responses, and T-cell cross-reactivity to recombinant Bet v 1.0101 (Bet v 1; birch), Cor a 1.0401 (Cor a 1; hazelnut), and Dau c 1.0104 (Dau c 1; carrot). A novel flow cytometry–based method using a 2-step staining process with fluorescent dyes was establis…

AdultMaleAllergyImmunologyCross ReactionsImmunoglobulin EFlow cytometryYoung Adultchemistry.chemical_compoundCorylusOral allergy syndromeAntigenT-Lymphocyte SubsetsFood allergymedicineHumansImmunology and AllergyBetulaCells CulturedPlant Proteinsmedicine.diagnostic_testbiologyChemistryfood and beveragesCarboxyfluorescein succinimidyl esterDendritic cellAllergensAntigens PlantImmunoglobulin EMiddle Agedmedicine.diseaseDaucus carotaCase-Control StudiesImmunologybiology.proteinPollenFemaleFood HypersensitivityJournal of Allergy and Clinical Immunology
researchProduct

Prospective, blinded comparison of cytology and DNA-image cytometry of brush biopsies for early detection of oral malignancy

2012

summary Objectives: Adjunctive techniques like DNA image cytometry (DNA-ICM) have been attributed to enhance the diagnostic performance of oral brush biopsies. The aim of the study was an evaluation of brush biopsies, analysed according to morphological criteria and by DNA-ICM vs. histological findings in a blinded prospective trial. Materials and methods: Eighty eight brush biopsies of 70 patients were sampled. Only clinical suspicious but not evident malignant oral lesions were included. Clinical diagnosis was leukoplakia (n = 36), lichen planus (n = 18), verruciform erythroplakia (n = 12), erythroleukoplakia (n = 9), erosion (n = 7) and induration (n = 6). Evaluation was conducted via hi…

AdultMaleCancer ResearchPathologymedicine.medical_specialtyCytodiagnosisMalignancySensitivity and SpecificityCytologyOral and maxillofacial pathologyImage Processing Computer-AssistedmedicineCarcinomaHumansSingle-Blind MethodProspective StudiesFalse Negative ReactionsMouth FloorEarly Detection of CancerAgedImage CytometryLeukoplakiaAged 80 and overErythroplakiaPloidiesbusiness.industryMouth MucosaHistologyDNA NeoplasmMiddle Agedmedicine.diseaseTongue Neoplasmsstomatognathic diseasesOncologyDysplasiaErythroplasiaCarcinoma Squamous CellFemaleMouth NeoplasmsLeukoplakia OralOral SurgerybusinessPrecancerous ConditionsCarcinoma in SituLichen Planus OralOral Oncology
researchProduct